DK0588797T3 - N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser - Google Patents
N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelserInfo
- Publication number
- DK0588797T3 DK0588797T3 DK92905647.1T DK92905647T DK0588797T3 DK 0588797 T3 DK0588797 T3 DK 0588797T3 DK 92905647 T DK92905647 T DK 92905647T DK 0588797 T3 DK0588797 T3 DK 0588797T3
- Authority
- DK
- Denmark
- Prior art keywords
- trihydroxy
- anthracenyl
- dioxo
- dihydroxy
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI910658A IT1244773B (it) | 1991-03-12 | 1991-03-12 | N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0588797T3 true DK0588797T3 (da) | 1996-06-17 |
Family
ID=11359001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92905647.1T DK0588797T3 (da) | 1991-03-12 | 1992-03-04 | N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser |
Country Status (21)
Country | Link |
---|---|
US (1) | US5451606A (da) |
EP (1) | EP0588797B1 (da) |
JP (1) | JP2979054B2 (da) |
KR (1) | KR100224330B1 (da) |
AT (1) | ATE134363T1 (da) |
AU (1) | AU661475B2 (da) |
CA (1) | CA2105683C (da) |
CZ (1) | CZ282997B6 (da) |
DE (1) | DE69208464T2 (da) |
DK (1) | DK0588797T3 (da) |
ES (1) | ES2084348T3 (da) |
FI (1) | FI113167B (da) |
GR (1) | GR3019069T3 (da) |
HU (1) | HU215436B (da) |
IT (1) | IT1244773B (da) |
MX (1) | MX9201055A (da) |
NO (1) | NO304592B1 (da) |
PT (1) | PT100216B (da) |
RU (1) | RU2111959C1 (da) |
SK (1) | SK280134B6 (da) |
WO (1) | WO1992016496A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ245989A (en) * | 1992-02-28 | 1995-02-24 | Lilly Industries Ltd | Anthraquinone derivatives and pharmaceutical compositions |
GB9417102D0 (en) * | 1994-08-24 | 1994-10-12 | Lilly Industries Ltd | Pharmaceutical compounds |
IT1276781B1 (it) * | 1995-06-23 | 1997-11-03 | Gentili Ist Spa | Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie |
GB2398780A (en) * | 2003-02-26 | 2004-09-01 | Arakis Ltd | 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as inhibitors of T-cell proliferation for treatment of autoimmune or inflammatory conditions |
CN102060809B (zh) * | 2009-05-01 | 2015-05-20 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种大黄酸衍生物及其制备和用途 |
CN102225913B (zh) * | 2011-04-07 | 2013-09-04 | 栗进才 | 大黄酸衍生物以及它们的治疗用途 |
RU2466134C1 (ru) * | 2011-06-24 | 2012-11-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Иркутский государственный университет" | Способ получения катионных комплексов палладия |
CN104557603A (zh) * | 2014-12-08 | 2015-04-29 | 石河子大学 | 一种大黄酸类化合物及制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA761627B (en) * | 1976-03-16 | 1978-01-25 | C Friedmann | Improvements in or relating to the treatment of arthritis |
US4966918A (en) * | 1989-01-27 | 1990-10-30 | Sloan-Kettering Institute For Cancer Research | Derivatives of chryosphanol |
-
1991
- 1991-03-12 IT ITMI910658A patent/IT1244773B/it active IP Right Grant
-
1992
- 1992-03-04 ES ES92905647T patent/ES2084348T3/es not_active Expired - Lifetime
- 1992-03-04 EP EP92905647A patent/EP0588797B1/en not_active Expired - Lifetime
- 1992-03-04 DK DK92905647.1T patent/DK0588797T3/da active
- 1992-03-04 AT AT92905647T patent/ATE134363T1/de not_active IP Right Cessation
- 1992-03-04 DE DE69208464T patent/DE69208464T2/de not_active Expired - Fee Related
- 1992-03-04 CA CA002105683A patent/CA2105683C/en not_active Expired - Fee Related
- 1992-03-04 WO PCT/EP1992/000479 patent/WO1992016496A1/en active IP Right Grant
- 1992-03-04 CZ CS931829A patent/CZ282997B6/cs not_active IP Right Cessation
- 1992-03-04 SK SK947-93A patent/SK280134B6/sk unknown
- 1992-03-04 HU HU9302510A patent/HU215436B/hu not_active IP Right Cessation
- 1992-03-04 JP JP4505494A patent/JP2979054B2/ja not_active Expired - Fee Related
- 1992-03-04 RU RU93057732A patent/RU2111959C1/ru not_active IP Right Cessation
- 1992-03-04 AU AU13596/92A patent/AU661475B2/en not_active Ceased
- 1992-03-04 KR KR1019930702709A patent/KR100224330B1/ko not_active IP Right Cessation
- 1992-03-04 US US08/117,065 patent/US5451606A/en not_active Expired - Fee Related
- 1992-03-09 PT PT100216A patent/PT100216B/pt active IP Right Grant
- 1992-03-11 MX MX9201055A patent/MX9201055A/es not_active IP Right Cessation
-
1993
- 1993-09-08 FI FI933925A patent/FI113167B/fi not_active IP Right Cessation
- 1993-09-10 NO NO933241A patent/NO304592B1/no not_active IP Right Cessation
-
1996
- 1996-02-22 GR GR960400457T patent/GR3019069T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0775129T3 (da) | 3-Benzoylbenzofuranderivater som thyroidhormonantagonister | |
LU91145I2 (fr) | FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX). | |
DZ1794A1 (fr) | Nouvelle formule pharmaceutique. | |
BR1100412A (pt) | Composto; método para propiciar tratamento imunomodulador; e composição farmacêutica para tratamento imunomodulador | |
GR3033528T3 (en) | Novel piperidine derivatives with paf antagonist activity | |
DK0588797T3 (da) | N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser | |
ATE181333T1 (de) | Azirdin-derivate, deren herstellung und verwendung | |
ES2108595A1 (es) | Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion. | |
ATE223915T1 (de) | Neue heterozyklische chemie | |
DE69315836D1 (de) | Pyrazolpyridine für die behandlung der anämie | |
ES2086528T3 (es) | Nuevos compuestos biciclicos sustituidos con amino. | |
PL313037A1 (en) | Phenoxphenylocyclopententenylohydroxyureas | |
MX9205365A (es) | Imidazolilmetil-piridinas y composicion farmaceutica que las contiene. | |
NZ236186A (en) | Pyrrolidine and piperidine derivatives and pharmaceutical compositions | |
ATE104313T1 (de) | Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus. | |
ATE166339T1 (de) | Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-deriv te | |
IL99777A0 (en) | Indole derivatives,processes for their preparation and pharmaceutical compositions containing them | |
ZA916977B (en) | Pharmaceutical compositions for use in treating aids | |
IL117083A (en) | Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical compositions containing these compounds | |
GR3035010T3 (en) | New derivatives of glycylanilides, preparation and therapeutical application |